Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/2704
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mamajonova Diyorakhon, Shukurov Farkhad | - |
dc.date.accessioned | 2022-10-09T06:39:56Z | - |
dc.date.available | 2022-10-09T06:39:56Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/2704 | - |
dc.description.abstract | Тo evaluate the safety, efficacy, and immunogenicity of COVID-19 vaccination in pregnant women. Materials and research methods. The study included 120 pregnant women vaccinated with the Gam-Kovid-Vak vaccine against COVID-19. Of these, 60 women were vaccinated in the second trimester of pregnancy (main group I) and 60 in the third trimester of pregnancy (main group II), and the comparison group consisted of 30 pregnant women who refused vaccination. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Узбекистан, Ташкент | en_US |
dc.subject | Coronavirus infection Pregnancy Vaccination Gam-Kovid-Vak vaccine Reactogenicity Immunogenicity | en_US |
dc.title | Сlinical and laboratory features of vaccination against COVID-19 in pregnant women | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Мамажанова Д.М. макола ТМА янги журналида.pdf | Сlinical and laboratory features of vaccination against COVID-19 in pregnant women | 330.53 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.